Loading clinical trials...
Loading clinical trials...
Ultrasonographic Evaluation of Ovarian Stroma in PCOS Women
The most common endocrine condition in reproductive women is polycystic ovary syndrome. It has a prevalence of 5-10%. According to the Rotterdam criteria, oligo/anovulation, clinic or biochemical hyperandrogenism, PCOS morphology in ultrasonography, and the presence of these two criteria are required for diagnosis. The echogenicity of the ovarian stroma, vascularity, ovarian size, cystic pattern density, and subcortical organization of cysts are all significant considerations in ultrasonographic evaluation.
Retrospective archive study. In the years 2018-2019, the ultrasonographic archives of PCOS women will be analyzed retrospectively in the Radiology department of Usak Education and Research Hospital. Ultrasonographic (Two-dimensional ultrasonography , conventional and other doppler) measurements of ovaries will be assessed in ultrasonographic data. Patient's data ( Menstrual cycle, androgenic findings, age, BMI etc..) will be obtained on the hospital records, PCOS patient's phenotype will be evaluated according to National Institutes Health (NIH) recommendations. The ovarian ultrasonographic findings of PCOS women will be compared. This study approved by Usak University Medical Faculty Ethical Committee April,06,2022. The Ethical Committee decision number is 57-57-04.
Age
18 - 38 years
Sex
FEMALE
Healthy Volunteers
Yes
İrem Şenyuva
Uşak, Turkey (Türkiye)
Start Date
June 13, 2022
Primary Completion Date
September 4, 2022
Completion Date
September 4, 2022
Last Updated
September 21, 2022
42
ACTUAL participants
OTHER
Lead Sponsor
Usak State Hospital
NCT06913335
NCT02831556
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06342934